Advertisement
For women undergoing cesarean delivery

SMFM: Chlorhexidine-Alcohol Best for Pre-Op Skin Antisepsis

0
Superior to iodine-alcohol for the prevention of surgical-site infection after cesarean delivery
For women at risk for late preterm delivery

SMFM: Betamethasone Shows Benefit in Late Preterm Cases

0
Significantly reduced rate of neonatal respiratory complications seen
Lipofilling seems safe for breast reconstruction after mastectomy for breast cancer

Lipofilling of Breast Doesn’t Up Breast Cancer Recurrence

0
No increase in locoregional recurrence, systemic recurrence, or second breast cancer
The Advisory Committee on Immunization Practices has approved the recommended adult immunization schedule for 2016. The recommendations are published as a clinical guideline in the Feb. 2 issue of the Annals of Internal Medicine.

ACIP Approves 2016 Adult Immunization Schedule

0
Changes to schedule for HPV, pneumococcal, and meningococcal vaccines
Women-only cardiac rehabilitation programs may confer behavioral and psychosocial advantages for women

Benefits for Women With Women-Only Cardiac Rehab

0
Improvements in women's health behaviors and psychosocial well-being versus mixed-sex rehab
Implementation of a surgical safety checklist correlated with a reduction in 90-day

Surgical Safety Checklist Linked to Drop in 90-Day Mortality

0
Implementation of checklist didn't cut 30-day mortality or readmission; linked to decrease in LOS
For obese women

Antenatal Metformin Cuts Maternal Weight Gain in Obese

0
Findings among women without diabetes with BMI of >35; no reduction in neonatal birth weight
For women with uterine cancer

Minimally Invasive Hysterectomy Beneficial in Uterine Cancer

0
Linked to favorable morbidity profile and does not compromise long-term survival
Few adults aged 45 years or older with subjective memory complaints report discussing these with a health care professional

Few Adults Discuss Subjective Memory Complaints With Doctors

0
Of adults aged 45 years and older reporting recent check-up, only 25.2 percent reported SMCs
Two HIV-1 vaccines

Novel Vaccine Platform Shows Promise for HIV-1

0
HIV-1 vaccines with adenovirus and HIV-1 envelope A insert are well-tolerated, elicit immune responses